Tela Bio Inc (NASDAQ: TELA) Sustains Positive Sentiment Post IPO

Tela Bio Inc (NASDAQ: TELA) went public on the 13th of November at an offer price of $13. The stock offer was for 4 million...

Could Berubicin Unlock Growth Potential for CNS Pharmaceuticals (CNSP)?

On the 13th of November, CNS Pharmaceuticals Inc closed its IPO of 2.125 million shares at $4. Since then, the company has been oscillating around this...

Phathom Pharmaceuticals (NASDAQ: PHAT) Holds Steady Pace a Month After IPO

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has been on an uptrend since it went public in October. This follows a series of financial and technical news...

Innate Pharma S.A (NASDAQ: IPHA) Certified a Great Place to Work by an Independent...

Innate Pharma S.A (NASDAQ: IPHA) has been gaining traction since it went public in September. The company has also made a number of positive announcements...

Galera Therapeutics Inc (NASDAQ: GRTX) Bounces Back to IPO Price Levels

Galera Therapeutics Inc (NASDAQ: GRTX) is now trading above its IPO price after a crash immediately after going public. The stock went public at an...

SiTime Corporation (NASDAQ: SITM) Gains Momentum Weeks after IPO

On the 25th of November SiTime Corporation (NASDAQ: SITM) announced that it had completed its IPO. The initial public offer was for 4,945,000 of the...

New Issue, 89bio Inc (NASDAQ: ETNB), Holds On To Gains a Month After IPO

89bio Inc (NASDAQ: ETNB) has been in consolidation for the better part of December. Nonetheless, it is still in gains compared to its IPO price....

Progyny Inc (NASDAQ: PGNY) Sustains Rally Weeks After Strong Q3 Results Post-IPO

Progyny Inc (NASDAQ: PGNY) has been one of the best performing, of the more recent IPOs. The company went public in October at a price...

Springworks Therapeutics (NASDAQ: SWTX) Boosted by Progress in Initial Phase of 2b ReNeu Clinical...

Springworks Therapeutics Inc (NASDAQ: SWTX) has gained significantly since it went public at an offer price of $18 in September. As of yesterday’s close, the...

Turning Point Therapeutics (NASDAQ: TPTX) Gains Ahead Of The Piper Jaffray 31ST Annual Healthcare...

The IPO craze that was there at the beginning of the year seems to have died out. However, there are a few that continue to...

Must Read